Literature DB >> 2013893

Non-secretory adenomas of the pituitary treated by trans-ethmoidal sellotomy.

G R Shone1, S H Richards, M D Hourihan, R Hall, J P Thomas, M F Scanlon.   

Abstract

A consecutive series of 35 clinically non-secretory pituitary adenomas treated surgically by the transethmodial approach is presented. Mean age at presentation was 60 years, with a male-to-female ratio of 2:1. These tumours present later than hormone secreting tumours: 90% were over 2 cm in diameter at operation. Seventy-one per cent of patients had impaired vision and 89% had hypopituitarism. Surgical treatment relieved or significantly improved visual fields in 79% of patients with impaired vision. Ninety-one per cent required permanent hormone replacement. Mean follow-up was for 4.4 years. Five tumours recurred, causing recurrent visual symptoms. No tumours recurred in those patients treated with postoperative radiotherapy, but follow-up in this group was only for a mean of 2.7 years.

Entities:  

Mesh:

Year:  1991        PMID: 2013893      PMCID: PMC1293132          DOI: 10.1177/014107689108400308

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

Review 1.  Nonsecreting pituitary tumors.

Authors:  A Klibanski
Journal:  Endocrinol Metab Clin North Am       Date:  1987-09       Impact factor: 4.741

2.  Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.

Authors:  B M Arafah
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

3.  Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.

Authors:  J S Bevan; C B Adams; C W Burke; K E Morton; A J Molyneux; R A Moore; M M Esiri
Journal:  Clin Endocrinol (Oxf)       Date:  1987-05       Impact factor: 3.478

4.  Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas.

Authors:  M J Ebersold; L M Quast; E R Laws; B Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

5.  Management of selected patients with hyperprolactinaemia by partial hypophysectomy.

Authors:  M F Scanlon; J R Peters; J P Thomas; S H Richards; W H Morton; S Howell; E D Williams; M Hourihan; R Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30
  5 in total
  5 in total

Review 1.  Endocrine inactive and gonadotroph adenomas: diagnosis and management.

Authors:  M Losa; P Mortini; R Barzaghi; A Franzin; M Giovanelli
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 3.  Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

4.  Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: A prospective series of 100 cases and brief review of the literature.

Authors:  Amit Kumar Thotakura; Mohana Rao Patibandla; Manas K Panigrahi; Gokul Chowdary Addagada
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

5.  Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study.

Authors:  Iris C M Pelsma; Marco J T Verstegen; Friso de Vries; Irene C Notting; Marike L D Broekman; Wouter R van Furth; Nienke R Biermasz; Alberto M Pereira
Journal:  Pituitary       Date:  2020-08       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.